Literature DB >> 2495172

Antiproliferative activity of gamma-interferon combined with lipopolysaccharide on murine adenocarcinoma: dependence on an L-arginine metabolism with production of nitrite and citrulline.

M Lepoivre1, H Boudbid, J F Petit.   

Abstract

Growth of the murine adenocarcinoma EMT6 was moderately inhibited by up to 32 units/ml of gamma-interferon (IFN-gamma). However, EMT6 growth was blocked by as low as 2 U/ml of IFN-gamma, when added with lipopolysaccharide. In the same time, the combination IFN-gamma + lipopolysaccharide induced synergistically the production of nitrite and citrulline by EMT6 cells. Synthesis of the two products was correlated with IFN-gamma concentrations. It required exogenous L-arginine and was inhibited by a methylated L-arginine derivative, NG-monomethyl-L-arginine. Inhibition was specific since urea synthesis was not reduced by NG-monomethyl-L-arginine. The L-arginine-dependent pathway was involved in EMT6 cytostasis mediated by IFN-gamma + lipopolysaccharide because cytostasis expression required L-arginine and was inhibited by NG-monomethyl-L-arginine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495172

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Kinetic characteristics of nitric oxide synthase from rat brain.

Authors:  R G Knowles; M Palacios; R M Palmer; S Moncada
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

2.  Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat.

Authors:  R G Knowles; M Merrett; M Salter; S Moncada
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

3.  Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase.

Authors:  C Estrada; C Gómez; J Martín-Nieto; T De Frutos; A Jiménez; A Villalobo
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamide.

Authors:  K Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 5.  Role of nitric oxide in parasitic infections.

Authors:  S L James
Journal:  Microbiol Rev       Date:  1995-12

6.  Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells.

Authors:  J Mayer; M L Woods; Z Vavrin; J B Hibbs
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Nitric oxide enhancement of melphalan-induced cytotoxicity.

Authors:  J A Cook; M C Krishna; R Pacelli; W DeGraff; J Liebmann; J B Mitchell; A Russo; D A Wink
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid.

Authors:  E Moilanen; L L Thomsen; D W Miles; D W Happerfield; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

9.  Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.

Authors:  P A Marsden; B J Ballermann
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.

Authors:  A Hajri; E Metzger; F Vallat; S Coffy; E Flatter; S Evrard; J Marescaux; M Aprahamian
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.